Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)

新发、再发和人畜共患疾病与多样性前沿 (FrERZD2)

基本信息

  • 批准号:
    10666744
  • 负责人:
  • 金额:
    $ 14.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Our nation is nearly paralyzed by the twin pandemics of COVID-19 and painful inequities in health outcomes among COVID-19 infected Americans of differing ethnicities. To help address these, we seek sponsorship to train the next generation of pandemic and emerging disease researchers in the FRONTIERS IN EMERGING, RE-EMERGING AND ZOONOTIC DISEASES AND DIVERSITY. FrERZD2 will launch and sustain three vital undertakings: sophisticated courses for skills development; relevant vital research experiences; and career mentoring activities. Responsive to PAR-20-289, it is designed for 16 trainees who are graduate and medical students, medical residents, postdoctoral fellows, and/or early-career faculty, and who also are US citizens or permanent residents. The week-long course will help to ensure that clinically active scientists (especially physicians) are able to obtain permission to participate. Too few laboratories are led by under-represented minority (URM) scientists, and not enough new URM trainees graduate. We seek 5 years of sponsorship to offer FrERZD2 courses at Morehouse School of Medicine (MSM), an HBCU, in 2021, 2023, and 2025 and Ponce Health Sciences University (PHSU), a Hispanic-Serving Institution, in 2022 and 2024. Under the overall directorship of Gerald Schatten from Pittsburgh, along with Jonathan Stiles at MSM, Idhaliz Flores from PHSU, and Calvin Simerly, also from Pittsburgh, FrERZD2 is overseen by an external scientific advisory committee. It offers dynamic advanced training courses consisting of daily lectures on emerging concepts, followed by extended discussion, laboratory research, technologically intense workshops, and informal seminars. Our similar training programs have recruited participants of whom 34% self-identify as African American/Black and 30% as Hispanic Americans; 66% are women, and 62% are from URM institutions. Six specific aims are proposed. Aim 1. Provide conceptual education and experimental training. Aim 2. Provide background information and self-reflective exercises and demonstrations to understand, appreciate, and address the historic and current underpinnings of inequities in the research workforce’s diversity and disparities in health care. Aim 3. Sponsor meaningful mentored research. Aim 4. Discuss career planning. Aim 5. Educate participants on the responsible conduct of research. Aim 6. Provide unbiased, quantitative, independent mechanisms to track trainees’ careers, comprehensively and longitudinally. The program’s name, FRONTIERS IN EMERGING, RE-EMERGING AND ZOONOTIC DISEASES AND DIVERSITY, acknowledges our hope that the COVID pandemic may soon recede significantly and our realization that other emerging, reemerging, and zoonotic diseases will arise that must be timely addressed. Overall, in conducting this program, we will continue to enhance and expand the research careers of the most promising scientists, with sensitivity to ensuring full diversity in the NIAID workforce.
项目总结 我们的国家几乎被新冠肺炎的双重流行病和令人痛苦的健康结果不平等所瘫痪 在不同种族的美国人中感染了新冠肺炎。为了帮助解决这些问题,我们寻求赞助 在新兴领域培养下一代大流行和新兴疾病研究人员, 再次出现的人畜共患疾病和多样性。FrERZD2将发射并维持三个至关重要的 承诺:技能发展的复杂课程;相关的重要研究经验;以及职业生涯 辅导活动。响应PAR-20-289,它是专为16名毕业生和医学实习生设计的 学生、住院医师、博士后研究员和/或职业生涯早期教师,也是美国公民或 永久居民。为期一周的课程将有助于确保临床活跃的科学家(特别是 医生)能够获得参与的许可。由代表不足的实验室领导的实验室太少了 少数族裔(URM)科学家,没有足够的新URM实习生毕业。我们寻求5年的赞助,以 于2021年、2023年和2025年在HBCU下属的莫尔豪斯医学院(MSM)开设FrERZD2课程,并 庞塞健康科学大学(PHSU),一个为拉美裔服务的机构,在2022年和2024年。在.之下 来自匹兹堡的Gerald Schatten以及MSM的Jonathan Siles,Idhaliz Flores来自 PHSU和同样来自匹兹堡的Calvin Simerly,FrERZD2由外部科学顾问监督 委员会审议阶段。它提供动态的高级培训课程,包括关于新兴概念的每日讲座, 随后是广泛的讨论、实验室研究、技术密集的研讨会和非正式的 研讨会。我们的类似培训计划已经招募了34%的参与者,其中34%的人自认为是非洲人 美国人/黑人,30%是西班牙裔美国人;66%是女性,62%来自URM机构。六 提出了具体的目标。目标1.提供概念教育和实验培训。目标2.提供 背景信息和自我反省练习和演示,以了解、欣赏和 解决研究人员多样性和差异方面的不平等的历史和现实基础 在医疗保健方面。目标3.赞助有指导意义的研究。目标4.讨论职业规划。目标5. 教育参与者负责任地进行研究。目标6.提供公正、量化、 建立独立的机制,全面和纵向跟踪受训人员的职业生涯。程序的名称, 新出现、重新出现和人畜共患疾病和多样性的前沿,承认 我们希望COVID大流行可能很快显著消退,我们意识到其他正在出现的, 一旦疫情再次出现,就会出现必须及时解决的人畜共患疾病。总体而言,在进行这项工作时 计划,我们将继续加强和扩大最有前途的科学家的研究生涯, 对确保NIAID工作人员的充分多样性的敏感性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GERALD SCHATTEN其他文献

GERALD SCHATTEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GERALD SCHATTEN', 18)}}的其他基金

Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)
通过本科教育促进美国原住民老龄化研究的多样性(美国原住民 ADAR)
  • 批准号:
    10460942
  • 财政年份:
    2021
  • 资助金额:
    $ 14.34万
  • 项目类别:
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)
通过本科教育促进美国原住民老龄化研究的多样性(美国原住民 ADAR)
  • 批准号:
    10172529
  • 财政年份:
    2021
  • 资助金额:
    $ 14.34万
  • 项目类别:
Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)
新发、再发和人畜共患疾病与多样性前沿 (FrERZD2)
  • 批准号:
    10313230
  • 财政年份:
    2021
  • 资助金额:
    $ 14.34万
  • 项目类别:
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)
通过本科教育促进美国原住民老龄化研究的多样性(美国原住民 ADAR)
  • 批准号:
    10619000
  • 财政年份:
    2021
  • 资助金额:
    $ 14.34万
  • 项目类别:
Forefronts in Substance Abuse Disorders during Pregnancy, Postpartum, and Pediatrics (FrSADP3)
妊娠期、产后和儿科药物滥用疾病的前沿 (FrSADP3)
  • 批准号:
    10741269
  • 财政年份:
    2018
  • 资助金额:
    $ 14.34万
  • 项目类别:
Frontiers in Addiction Research and Pregnancy
成瘾研究和怀孕的前沿
  • 批准号:
    10113573
  • 财政年份:
    2018
  • 资助金额:
    $ 14.34万
  • 项目类别:
Frontiers in Addiction Research and Pregnancy
成瘾研究和怀孕的前沿
  • 批准号:
    9532481
  • 财政年份:
    2018
  • 资助金额:
    $ 14.34万
  • 项目类别:
Frontiers in Addiction Research and Pregnancy
成瘾研究和怀孕的前沿
  • 批准号:
    10359163
  • 财政年份:
    2018
  • 资助金额:
    $ 14.34万
  • 项目类别:
Frontiers in Alzheimer's and Aging Research (FrA2R)
阿尔茨海默病和衰老研究前沿 (FrA2R)
  • 批准号:
    10441312
  • 财政年份:
    2012
  • 资助金额:
    $ 14.34万
  • 项目类别:
Rehabilitative and Regenerative Medicine for Minority Health & Health Disparities
少数民族健康的康复和再生医学
  • 批准号:
    8542883
  • 财政年份:
    2012
  • 资助金额:
    $ 14.34万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 14.34万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 14.34万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 14.34万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 14.34万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 14.34万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 14.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了